Latest market price
5.96
+0.16+2.76%
BIOAQT11BioAge Labs Inc.·NASDAQ
5.96+2.76%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 02, 20268-KCurrent report
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 05, 20268-KCurrent report
Aug 05, 202610-QQuarterly report
Jul 01, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20268-KCurrent report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 08, 20268-KCurrent report
May 08, 202610-QQuarterly report
Apr 27, 2026SC 13GBeneficial ownership statement (passive)
Apr 24, 20264Statement of changes in beneficial ownership
Apr 21, 2026ARSAnnual report to shareholders
Apr 21, 2026DEFA14AAdditional proxy soliciting materials
Apr 21, 2026DEF 14ADefinitive proxy statement
Apr 03, 20264Statement of changes in beneficial ownership
Apr 01, 2026144Notice of proposed sale of restricted securities
Mar 24, 2026S-8Registration of employee benefit securities
Mar 24, 20268-KCurrent report